Clinical Trials · NCT05607004

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Name: (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Active Not RecruitingPhase 2GHRP-6 Gonadorelin

Phase: Phase 2
Recruitment status: Active Not Recruiting
Sponsor: Atossa Therapeutics, Inc.
Enrollment: 87
Start date: Feb 2023
Locations: 14 sites, United States
Primary endpoint: PK Cohort - (Z)-endoxifen steady-state plasma concentrations

View Ghrp-6 compound reference